Best Peptides for Skin Rejuvenation
Anti-aging skin peptides researched for collagen production, wrinkle reduction, and skin repair.
Understanding Skin Rejuvenation Peptides
Skin peptides represent one of the most commercially successful applications of peptide science. GHK-Cu is backed by extensive research showing collagen stimulation, skin tightening, and wound healing. Matrixyl (palmitoyl pentapeptide) stimulates collagen synthesis and is found in many commercial skincare products. Epithalon may support skin health through its effects on cellular aging. These peptides can be applied topically, injected, or used in combination with microneedling for enhanced penetration.
Key Considerations
- Topical application is common for skin-specific benefits
- Microneedling can enhance peptide penetration
- Sun protection is essential alongside any skin treatment
- Results are gradual - expect 4-12 weeks for visible changes
- Quality of peptide products varies widely in the skincare market
FDA Approved Options (3)
Melanotan I
Also: Afamelanotide, Scenesse, MT-1
Melanotan I is the research name for afamelanotide, a 13-amino-acid synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), also written as [Nle4, D-Phe7]-alpha-MSH or NDP-MSH. It is the only melanocortin peptide with regulatory approval: sold as Scenesse, it was approved by the EMA in 2014 and the FDA in 2019 to increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP). It is given as a 16 mg bioresorbable implant under the skin by a clinician, not as a tanning shortcut.
Lanreotide
Also: Somatuline, Somatuline Depot
Lanreotide is an eight-amino-acid somatostatin analog, a close cousin of octreotide, given as a long-acting deep-injection gel (Somatuline Depot/Autogel) usually once a month. It is FDA-approved for acromegaly and for gastroenteropancreatic neuroendocrine tumors, and it carries an approval for carcinoid syndrome. It is established prescription medicine, not an experimental compound.
Pegvisomant
Also: Somavert
Pegvisomant (brand name Somavert) flips the usual acromegaly strategy on its head: instead of telling the tumor to make less growth hormone, it blocks growth hormone's receptor on target tissues directly. It is a PEGylated, genetically modified version of human growth hormone that acts as a receptor antagonist, FDA-approved in 2003 for acromegaly patients who do not respond well to surgery or other drugs. It is the single most effective option for normalizing IGF-1, which is why it is a key second-line therapy.
Research Peptides (12)
These peptides are being researched but are not FDA approved. They should only be considered for research purposes or under medical supervision.
GHK-Cu
Clinical TrialsGHK-Cu is the copper(II) complex of GHK, a naturally occurring human tripeptide (glycyl-L-histidyl-L-lysine) found in blood plasma, saliva and urine, whose levels decline with age. It is researched and widely used in cosmetic skincare for skin regeneration, wound healing, collagen support and anti-aging. It is not an FDA-approved drug; it appears in over-the-counter cosmetics and as a research or compounded peptide, with most human evidence coming from small topical-skincare studies.
Melanotan II
ResearchMelanotan II is a synthetic copy of alpha-melanocyte-stimulating hormone (alpha-MSH), nicknamed the tanning peptide because it darkens skin without much sun. It also triggers erections and can blunt appetite, which is why it became the template for the FDA-approved drug bremelanotide (PT-141). Melanotan II itself is not approved by the FDA or EMA and is sold only as an unregulated research chemical.
Snap-8
ResearchSNAP-8 (Acetyl Octapeptide-3) is a synthetic eight-amino-acid topical cosmetic peptide, an extended cousin of Argireline that adds two residues to the same SNAP-25 mimic sequence. It is marketed as a needle-free way to soften expression lines, especially on the forehead and around the eyes. It is a cosmetic ingredient, not an approved drug, and the human evidence behind it is thin and mostly comes from the manufacturer.
Argireline
ResearchArgireline is the trade name for acetyl hexapeptide-8 (sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2, also called acetyl hexapeptide-3), a synthetic peptide sold in anti-aging creams as a topical, needle-free alternative to Botox. It is designed to relax the muscle contractions behind expression lines. It is a cosmetic ingredient, not an FDA-approved drug, and the human efficacy data are genuinely mixed rather than settled.
Matrixyl
ResearchMatrixyl is the trade name (Sederma) for palmitoyl pentapeptide-4, also written Pal-KTTKS, a collagen-fragment peptide attached to a fatty acid so it can cross skin. Unlike Botox-mimic peptides, it does not touch muscle: it signals skin cells to rebuild collagen, so it is aimed at fine lines, firmness and skin texture rather than expression wrinkles. It is a cosmetic ingredient with one of the better-documented topical studies in the peptide space, though far short of drug-grade proof.
Matrixyl 3000
ResearchMatrixyl 3000 is Sederma's follow-up to the original Matrixyl, a fixed pair of two fatty-acid-tagged peptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The idea is a one-two punch: one peptide tells skin to rebuild collagen, the other calms the low-grade inflammation that wears collagen down. It is a cosmetic ingredient aimed at firmness, fine lines and aging skin, with supportive but mostly company-generated evidence.
Copper Peptide AHK-Cu
ResearchAHK-Cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. It is the lesser-known sibling of the naturally occurring GHK-Cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. It is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study.
LL-37
Clinical TrialsLL-37 is the only cathelicidin antimicrobial peptide humans make, a 37-amino-acid, positively charged, helical fragment cut from a precursor protein called hCAP-18. It is a frontline player in the innate immune system, part of the body's chemical defense against bacteria, viruses, and fungi. This is mainstream, heavily studied human biology, not a fringe research peptide, though LL-37 itself is not an approved drug.
NAD+ Precursors
Clinical TrialsNAD+ precursors are not peptides. They are small molecules, mainly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), that the body converts into NAD+, a coenzyme every cell needs to make energy and run repair enzymes. NAD+ falls with age, so these precursors are sold as anti-aging and metabolic supplements. Human trials confirm they reliably raise blood NAD+ levels, but clear proof of real health benefits in people is still missing.
KPV
PreclinicalKPV is a tiny tripeptide, just three amino acids (lysine, proline, valine), that forms the tail end of the natural hormone alpha-MSH. It is studied almost entirely as an anti-inflammatory agent, particularly for gut and skin inflammation. There are no registered human clinical trials proving its benefits in people; the evidence base is cell-culture and animal studies, so anything you read about it treating disease is preliminary.
Cartalax
PreclinicalCartalax is a synthetic tripeptide (Ala-Glu-Asp, or AED) from the Khavinson family of short peptide bioregulators, studied as a cartilage and connective-tissue regulator. It is a research compound, not an approved drug, and no registered human clinical trials exist.
Thymosin Beta-4
Clinical TrialsThymosin beta-4 (Tbeta4) is a small 43 amino acid peptide found in nearly every cell in the body, originally isolated from the thymus. Its main job is binding and sequestering G-actin, the building block of the cell's internal scaffolding, which lets it influence cell movement, wound repair, and tissue regeneration. It is researched heavily for healing of skin, cornea, and heart tissue, but it is not an FDA-approved drug. (The injectable sold as TB-500 is a synthetic fragment marketed as related to Tbeta4, not the full natural peptide.)
Frequently Asked Questions
What is the best peptide for skin rejuvenation?
GHK-Cu is the most researched skin peptide, with studies showing increased collagen production, improved skin elasticity, and reduced wrinkles. It also promotes wound healing and has antioxidant properties.
Do collagen peptides actually work?
Bioactive collagen peptides have clinical evidence showing improvements in skin elasticity, hydration, and wrinkle depth. GHK-Cu specifically signals skin cells to produce more collagen. Topical peptides work best with proper skin penetration methods.
How should I use skin peptides?
Topical serums with GHK-Cu or Matrixyl are the most common approach. Apply to clean skin before moisturizer. Microneedling before application enhances absorption. Some people use subcutaneous GHK-Cu injections for systemic skin benefits.
Explore Other Goals
Compare Peptides Side-by-Side
Use our comparison tool to evaluate multiple peptides at once.
Peptide Reconstitution Calculator
Calculate exact dilution volumes, syringe units, and doses per vial for any peptide.
Get Weekly Peptide Research Updates
New peptides, studies, and FDA changes delivered to your inbox.